111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-0.98%
Revenue decline while JHX shows 4.18% growth. Joel Greenblatt would examine competitive position erosion.
No Data
No Data available this quarter, please select a different quarter.
-70.36%
Gross profit decline while JHX shows 3.47% growth. Joel Greenblatt would examine competitive position.
-70.06%
Both companies show margin pressure. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-92.61%
EBITDA decline while JHX shows 1.80% growth. Joel Greenblatt would examine position.
-93.10%
EBITDA margin decline while JHX shows 3.40% growth. Joel Greenblatt would examine position.
-93.49%
Both companies show declining income. Martin Whitman would check industry conditions.
-93.42%
Both companies show margin pressure. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
133.96%
Tax expense growth while JHX reduces burden. John Neff would investigate differences.
-0.98%
Both companies show declining income. Martin Whitman would check industry conditions.
0.00%
Net margin growth while JHX declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.04%
Share count reduction exceeding 1.5x JHX's 0.09%. David Dodd would verify capital allocation.
-0.02%
Diluted share reduction while JHX shows 0.24% change. Joel Greenblatt would examine strategy.